This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 825835.

€ 6.527.563,75

01/01/2019 – 31/12/2022 (4 years)

Barcelona Supercomputing Center


German Cancer Research Center

Ontario Institute for Cancer Research

Centre National De La Recherche Scientifique

Stichting Hartwig Medical Foundation

Fundacio Centre De Regulacio Genomica

European Molecular Biology Laboratory

Consorci Institut D’investigacions Biomediques August Pi I Sunyer

Institut Catala D’oncologia

Vall d’Hebron Institute of OncologyUniversitatsklinikum Heidelberg

Charite – Universitaetsmedizin Berlin

Institut Curie

Royal Institution for the Advancement of Learning Mcgill University

Universidad Del Pais Vasco/ Euskal Herriko Unibertsitatea

Heidelberger Akademie Der Wissenschaften

Linq Management

Steinbeis Transfer

Why it matters

EUCANCan aims at supporting and enhancing modern oncology, by implementing a cultural, technological and legal integrated framework across Europe and Canada, to enable and facilitate the efficient analysis, management and sharing of cancer genomic data.

This cooperative framework is not only expected to immediately contribute to improve biomedical research in cancer, but to also serve as a model for globalizing and enriching personalised medicine initiatives, allowing the exchange of data, clinical experience and information across different national health systems.

What ECPC does

ECPC Chair of Scientific Committee Francesco de Lorenzo sits on the EUCANCan Advisory Board to ensure the project activities are in line with the needs of cancer patients by actively participating in discussions and providing feedback and input on research activities and outputs.

EU flag logo

This project is funded by the European Union.